EDGAR Filing Documents for 0001396814-17-000018

Form 8-K - Current report:

SEC Accession No. 0001396814-17-000018

Filing Date

2017-06-29

Accepted

2017-06-29 16:39:17

Documents

Period of Report

2017-06-29

Items

Item 2.05: Cost Associated with Exit or Disposal Activities
Item 2.06: Material Impairments

Document Format Files

Seq	Description	Document	Type	Size
1	8-K	pcrx8-kx62917.htm	8-K	23147
	Complete submission text file	0001396814-17-000018.txt		24420

Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054

Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560

Pacira Pharmaceuticals, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 17938790
SIC: 2834 Pharmaceutical Preparations